You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Protease inhibitor

Showing 1 - 25 of 8,115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Minneapolis (Shionogi Protease Inhibitor (S-217622), )

Recruiting
  • COVID-19
  • Shionogi Protease Inhibitor (S-217622)
  • placebo
  • Minneapolis, Minnesota
    University of Minnesota
Jan 12, 2023

SLPI for Prostate Cancer

Recruiting
  • Prostate Cancer
  • Prostatic Neoplasm
  • Secretory leukocyte protease inhibitor (SLPI) in prostate cancer
  • +2 more
  • Florence, Tuscany, Italy
    Careggi University Hospital
May 6, 2022

HIV Trial in Bangkok (generic single tablet TAF/FTC/DTG)

Active, not recruiting
  • HIV
  • generic single tablet TAF/FTC/DTG
  • Bangkok, Thailand
  • +1 more
Mar 22, 2022

HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

Active, not recruiting
Has Results
  • HIV-1 Infection
  • Doravirine, Tenofovir, Lamivudine
  • +4 more
  • (no location specified)
Sep 2, 2022

Multiple Myeloma Trial in Tianjin (Anlotinib Hydrochloride Capsule)

Recruiting
  • Multiple Myeloma
  • Anlotinib Hydrochloride Capsule
  • Tianjin, Tianjin, China
    InstituteHBDH
Sep 18, 2022

Covid19 Trial in South Africa, United States (Part A: Upamostat 200 mg, Part A: Upamostat 400 mg, Part A and B: Placebo)

Suspended
  • Covid19
  • Part A: Upamostat 200 mg
  • +3 more
  • Cutler Bay, Florida
  • +16 more
Aug 2, 2022

Hepatitis C, HIV Coinfection Trial in Aurora (TDF with a boosted protease inhibitor, TAF with a boosted protease inhibitor, TAF

Completed
Has Results
  • Hepatitis C
  • HIV Coinfection
  • TDF with a boosted protease inhibitor
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
Jan 21, 2021

HIV I Infection, Adiposity Trial in Saint Louis (Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose

Recruiting
  • HIV I Infection
  • Adiposity
  • Frequently sampled glucose tolerance testing
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 15, 2022

HIV Trial in United States (Indinavir sulfate, Ritonavir, Amprenavir)

Completed
  • HIV Infections
  • Indinavir sulfate
  • +5 more
  • Palo Alto, California
  • +7 more
Oct 28, 2021

Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx Trial in Philadelphia

Active, not recruiting
  • Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx
  • Nelfinavir (Viracept®) 1250 mg
  • FMISO
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 30, 2021

HIV Trial in United States (Indinavir sulfate, Ritonavir, Nelfinavir mesylate)

Completed
  • HIV Infections
  • Indinavir sulfate
  • +3 more
  • San Francisco, California
  • +14 more
Oct 27, 2021

Human Immunodeficiency Virus Type 1 Trial in Worldwide (D/C/F/TAF, Boosted Protease Inhibitor (bPI), FTC/TDF)

Completed
Has Results
  • Human Immunodeficiency Virus Type 1
  • Phoenix, Arizona
  • +81 more
Nov 25, 2021

HIV-1-infection Trial in Kenya (Dolutegravir)

Completed
  • HIV-1-infection
  • Kiambu, Kenya
  • +3 more
Jan 26, 2022

HIV/AIDS Trial in Worldwide (Biktarvy, Symtuza)

Recruiting
  • HIV/AIDS
  • Antwerp, Belgium
  • +47 more
Jan 9, 2023

HIV Trial in Puerto Rico, United States (lopinavir/ritonavir, indinavir sulfate, tenofovir disoproxil fumarate)

Completed
  • HIV Infections
  • Los Angeles, California
  • +13 more
Oct 28, 2021

Aging-related Inflammation in HIV-infected Patients Trial in Badalona (Raltegravir, PI-based regimen, Atorvastatin)

Completed
Has Results
  • Aging-related Inflammation in HIV-infected Patients
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol Hospital
Oct 7, 2020

HIV Trial in United States (Fosamprenavir, Lopinavir/Ritonavir, Ritonavir)

Completed
  • HIV Infections
  • Los Angeles, California
  • +12 more
Oct 28, 2021

Advanced Solid Tumors Trial in United States (KSQ-4279, KSQ-4279 will be combined in separate cohorts, including combination

Recruiting
  • Advanced Solid Tumors
  • KSQ-4279
  • KSQ-4279 will be combined in separate cohorts, including combination with an oral PARPi (poly adenosine diphosphate-ribose polymerase inhibitor)
  • Boston, Massachusetts
  • +4 more
Apr 5, 2022

HIV-1-infection, Antiretroviral Therapy Trial in Port-au-Prince (Continuation of boosted PI, B/F/TAF)

Not yet recruiting
  • HIV-1-infection
  • Antiretroviral Therapy
  • Port-au-Prince, Haiti
    GHESKIO
Jul 30, 2020

HIV Trial in United States (Lopinavir/Ritonavir, Abacavir sulfate, Nevirapine)

Completed
  • HIV Infections
  • Los Angeles, California
  • +22 more
Oct 28, 2021

HIV Trial in United States (Raltegravir (MK-0518), Placebo)

Completed
Has Results
  • HIV Infections
  • Raltegravir (MK-0518)
  • Placebo
  • Birmingham, Alabama
  • +19 more
Nov 2, 2021

Single Versus Double Ritonavir-boosted Protease Inhibitor-Based

Completed
  • HIV Infection
  • HIV Infections
  • ritonavir-boosted PI-based second line treatments
  • two PIs boosted by low dose ritonavir or one PI plus full dose ritonavir
  • Bangkok, Thailand
  • +7 more
Jul 15, 2020

HIV Related Insulin Resistance, Protease Inhibitor Related Insulin Resistance, Endoplasmic Reticulum Stress Trial in Saint Louis

Completed
Has Results
  • HIV Related Insulin Resistance
  • +2 more
  • Tauroursodeoxycholic acid
  • Placebo tablet
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 23, 2020

HIV, Pregnancy Trial in Worldwide (Lamivudine, Lamivudine/Zidovudine, Nelfinavir mesylate)

Completed
  • HIV Infections
  • Pregnancy
  • Los Angeles, California
  • +48 more
Oct 28, 2021

COVID19 Trial in Padova (Nafamostat Mesilate, Placebo)

Recruiting
  • COVID19
  • Nafamostat Mesilate
  • Placebo
  • Padova, Italy
    Azienda Ospedale Università di Padova
Jun 4, 2021